Diseases, Conditions, Syndromes

Are autoantibodies in COVID-19 less harmful than previously thought?

Critically ill COVID-19 patients often have antibodies in their blood that bind to the body's own structures, so-called autoantibodies. Scientists from the BIH at Charité and the Max Delbrück Center have now discovered ...

Medications

Encouraging findings for Batten disease drug

The FDA-approved, lipid-lowering medication gemfibrozil may prevent the progression of juvenile Batten disease, according to researchers at RUSH. Results from the study were recently published in The Journal of Neuroscience.

Diseases, Conditions, Syndromes

Discovery of a potential therapeutic target for ALS

University of Malta researchers have discovered a potential new drug target for amyotrophic lateral sclerosis (ALS), according to a new study published in the Neurobiology of Aging journal.

page 15 from 40